Stein Steven H
CIK 0001673776
EVP & Chief Medical OfficerDirector
Filings
31
Latest May 20, 2026
Issuers covered
4
Showing
31 of 31
Page 1
Track record
11 of 11 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 45% | -3.8% | -0.8% | +10.9% | -27.9% |
| 90 days | 11 | 73% | -0.4% | +4.5% | +22.7% | -33.4% |
| 180 days | 10 | 70% | -5.5% | +5.6% | +21.5% | -52.3% |
| 365 days | 5 | 20% | -13.7% | -6.1% | +15.8% | -42.5% |
Issuers
Companies where Stein Steven H has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INCY | Incyte Corp | 27 | May 20, 2026 |
| THRX | Theseus Pharmaceuticals, Inc. | 2 | Feb 14, 2024 |
| KURA | Kura Oncology, Inc. | 1 | Jun 23, 2022 |
| RPTX | Repare Therapeutics Inc. | 1 | Jun 20, 2024 |
All filings
31 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|